Predicted targets of miR‐194 in RCC include HIF1A, MAPK1, RAP1B, AKT2; which are major components of the ccRCC pathogenesis as well as other oncogenic pathways 23. The gene discussed is RAP1B; the disease is renal cell carcinoma.